Novoseven 1Mg Dry Vial Of 1 Powder For Injection

• Haemophilia A or B with inhibitors: Antibodies can block usual clotting factors, so eptacog alfa helps control bleeding through a different clotting route.
• Acquired haemophilia: Autoantibodies can interfere with clotting, and specialist treatment may help stop bleeding when usual factor treatment is blocked.
• Congenital factor seven deficiency: Missing factor seven can delay clot formation, and this medicine supplies activated clotting activity to help control bleeding.
• Glanzmann's thrombasthenia: Poor platelet function can cause prolonged bleeding, and this medicine may help when platelet transfusions are ineffective or unsuitable.
• Surgical or dental bleeding prevention: Specialist teams may use it around selected invasive procedures to reduce bleeding risk in people with suitable bleeding disorders.
• Severe bleeding after childbirth: A specialist may consider this treatment when heavy bleeding does not respond adequately to usual care.

• Injection-site reaction: Pain, redness or swelling can develop where the needle enters the vein or muscle. Tell the healthcare professional if it becomes severe or spreads.
• Allergic reaction: A rash, wheezing or sudden swelling may signal sensitivity to the medicine. Get emergency medical help for breathing difficulty or swelling of the face, lips or throat.
• Unwanted clotting: Eptacog alfa can rarely cause clots away from the bleeding site. Seek emergency care for chest pain, breathlessness, one-sided weakness or a painful swollen limb.

• Keep your bleeding-disorder treatment record available for every healthcare visit.
• Tell every healthcare professional that you receive eptacog alfa before a procedure.
• Report sudden chest pain, severe headache, limb swelling, breathlessness or weakness urgently.
• Do not use a vial if the prepared solution is cloudy, discoloured or contains visible particles.

Overdose

Missed a Dose

Interactions with other medicines